VOLIROP 3.125 carvedilol 3.125mg tablets Bottle Australia - English - Department of Health (Therapeutic Goods Administration)

volirop 3.125 carvedilol 3.125mg tablets bottle

strides pharma science pty ltd - carvedilol, quantity: 3.125 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; lactose monohydrate; polysorbate 80; sucrose; colloidal anhydrous silica; macrogol 400; povidone; titanium dioxide; hypromellose - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Carvedilol Sandoz New Zealand - English - Medsafe (Medicines Safety Authority)

carvedilol sandoz

sandoz new zealand limited - carvedilol 12.5mg;   - tablet - 12.5 mg - active: carvedilol 12.5mg   excipient: colloidal silicon dioxide crospovidone iron oxide red iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose povidone - carvedilol sandoz is indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).

Carvedilol Sandoz New Zealand - English - Medsafe (Medicines Safety Authority)

carvedilol sandoz

sandoz new zealand limited - carvedilol 25mg;   - tablet - 25 mg - active: carvedilol 25mg   excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose povidone - carvedilol sandoz is indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).